Tag

Screening Guidelines

All articles tagged with #screening guidelines

health7 days ago•16 min saved

Blood Tests Enter Colorectal Cancer Screening Guidelines

The American Cancer Society has added blood-based screening to its colorectal cancer guideline for adults 45+ at average risk who decline or have not completed visual exams or stool tests, endorsing Guardant Health's Shield blood test alongside at-home stool tests such as Cologuard Plus and ColoSense; however, blood-based tests are less sensitive for precancerous polyps and are considered a secondary option when other tests aren't completed, with colonoscopy remaining the gold standard.

via KSL.com|

#american-cancer-society #blood-based-testing #colorectal-cancer

health7 days ago•0 min saved

ACS Adds Blood Test to Colorectal Cancer Screening Options to Boost Uptake

The American Cancer Society updated colorectal cancer screening guidelines to include a blood test, aiming to provide more options and increase screening rates among adults 45 and older, noting that about a third of eligible adults are not up to date and that early detection improves outcomes.

via The Washington Post|

#american-cancer-society #blood-test #colorectal-cancer

health7 days ago•3 min saved

Blood Test Joins Colorectal Cancer Screening to Reach the Underscreened

The American Cancer Society added the Shield blood test as a recommended option for colorectal cancer screening for people who can’t or won’t have colonoscopies or stool tests. It’s not a replacement for colonoscopy; it’s intended to increase screening among the under-screened. The Shield test detects DNA fragments from tumors and, while about 83% effective at detecting existing cancer, is less reliable for early-stage disease and precancerous polyps. It costs $895 out of pocket and insurance coverage isn’t guaranteed. Most doctors stress that colonoscopy remains the gold standard and screening options vary (stool tests, Cologuard/ColoSense) with follow-up colonoscopy required if a test is positive. Experts say expanding options could boost uptake, since screening should start at 45 for average risk.

via NBC News|

#colonoscopy #colorectal-cancer-screening #guardant-health

health7 days ago•11 min saved

ACS Brings Blood Screening Into Colorectal Cancer Guidelines

ACS updates colorectal cancer screening guidelines to include a blood-based test (the Shield test) for average-risk adults 45+ who decline visual or stool tests; Shield detects tumor DNA in blood with about 83% sensitivity for cancer and is recommended every three years, but is less sensitive for precancerous polyps, so it is not the first choice. The update also adds at-home stool tests (Cologuard Plus, ColoSense) and maintains colonoscopy as the gold standard. The aim is to boost screening rates, especially among younger adults, with Medicare coverage offering no co-pay for Shield for many beneficiaries.

via CNN|

#blood-based-testing #colorectal-cancer #early-onset-cancer

health16 days ago•22 min saved

Mammogram Timing Clash: Start Age and Frequency Vary by Guideline

Guidelines for routine breast screening differ: ACP recommends average‑risk women start at 50–74 with biennial mammograms, USPSTF suggests starting at 40 with the same 2‑year interval, and ACS has long urged yearly screening starting at 45 (with 40 optional) and then switching to every year or every other year for older women. The disagreement reflects challenges in predicting risk and balancing benefits with harms, especially since dense breasts and tumor biology vary. New research (like the WISDOM trial) and tools to assess individual risk could tailor schedules in the future, including the potential use of DBT and broader gene testing. For now, consult a doctor about personal risk and stick with a chosen screening plan.

via VINnews|

#age-40 #breast-cancer-screening #health

health18 days ago•5 min saved

Mammogram timing diverges as experts push toward personalized screening

Guidelines on when to start and how often to screen with mammograms clash among major groups, reflecting imperfect risk prediction. ACP recommends average-risk women 50–74 get mammograms every two years, with 40–49 discussing pros/cons; USPSTF starts at 40 every two years; ACS favors yearly screening for 45–54 (start at 40 optional) and allows switching after 55. Dense breasts and emerging tools like 3D mammography, broader genetic risk tests, and AI risk models may tailor later practice, but experts say regular screening remains most beneficial when a shared plan is followed with a clinician.

via NBC News|

#breast-cancer #breast-density #health

health1 month ago•55 min saved

Never-smoker lung cancer on the rise as genetics and pollution drive new cases

Lung cancer is increasingly diagnosed in healthy, non-smokers—often younger women—driven by genetic changes like ALK and environmental factors such as air pollution and burn-pit toxins; experts urge expanding screening beyond smoking history and highlight targeted therapies that can turn advanced disease into a manageable condition.

via Daily Mail|

#alk-mutation #environmental-exposure #health

health3 months ago•4 min saved

Rectal Cancer Surges Among Younger Adults, Prompting Screening Reconsideration

A new American Cancer Society report finds rectal cancer rates are rising across ages and are driving an uptick in colorectal cancer diagnoses among people under 65 in the U.S., with rectal cancers now making up about a third of cases. From 2018–2022, rectal cancer rose about 1% annually in all ages, while younger groups saw faster increases (up to 3% for ages 20–49). The trend is prompting discussion on screening age (USPSTF has lowered it to 45) and faster symptom education/referrals, as many under-50 patients are diagnosed at advanced stages. Emphasized risk factors include smoking, excess weight, physical inactivity, and diet; reducing these could help lower risk.

via NBC News|

#american-cancer-society #colorectal-cancer #health

health3 months ago•6 min saved

Colorectal Cancer Goes Younger: Nearly Half of New Cases Are Under 65

New American Cancer Society data show nearly half of colorectal cancers now occur in adults under 65, with rising cases in ages 50–64 and a notable increase in rectal cancer, likely reflecting a birth-cohort effect and environmental influences; experts emphasize paying attention to symptoms and that screening for average risk starts at age 45, while treatment varies by stage and may involve surgery, chemotherapy, and radiation for rectal cancer.

via The New York Times|

#birth-cohort #colorectal-cancer #epidemiology

health3 months ago•6 min saved

Colorectal cancer screening moves younger: why 45 is the new starting age and what to expect

The piece explains that colorectal cancer is increasingly affecting younger people, leading to guidelines that now start average-risk screening at age 45 with a colonoscopy every 10 years (or stool tests as alternatives), notes that a family or personal history can trigger earlier testing, and discusses symptoms, costs, and the role of noninvasive tests like Cologuard and FIT. It also highlights that lifestyle factors and access to care influence risk and screening uptake.

via NBC News|

#age-45 #colonoscopy #colorectal-cancer

health3 months ago•4 min saved

Colorectal Cancer Surges in Young Adults — How to Cut Risk and Get Screened

Colorectal cancer is rising among people under 50, with possible links to diet, alcohol, smoking, obesity, and gut microbiome imbalances; early warning signs include blood in stool, abdominal pain, and changes in bowel habits, prompting medical evaluation. Screening for average risk typically begins at age 45 (with colonoscopy emphasized for higher risk), while high-risk individuals may need earlier testing. Catching cancer early can yield 80–90% 5-year survival, whereas advanced or metastatic disease has much poorer outcomes. Reducing risk involves regular exercise, a fiber-rich diet with less red/processed meat, maintaining a healthy weight, moderating alcohol and avoiding tobacco, and sharing family history with your clinician to tailor screening and prevention.

via PBS|

#early-onset-colorectal-cancer #gut-microbiome #health

health4 months ago•3 min saved

Colorectal cancer rises to No. 1 cancer killer for Americans under 50

An analysis of nearly 1.3 million cancer deaths in Americans under 50 from 1990–2023 shows colorectal cancer is now the leading cancer killer in this group, with deaths increasing about 1% annually since 2005 while overall under-50 cancer deaths have fallen about 44% since 1990. Other top cancers declined, making the colorectal rise an outlier. Possible contributors include obesity, inactivity, diet, and microbiome changes, but the exact cause is unclear. The study underscores the importance of awareness and screening, with USPSTF guidance now recommending universal screening starting at 45 (earlier for high-risk groups), and noting roughly half of under-50 cases occur at ages 45–49.

via NBC News|

#cancer-mortality #colorectal-cancer #health

science4 months ago•35 min saved

Colorectal cancer emerges as a rising threat among under-50s amid overall cancer drops

A American Cancer Society study published in JAMA finds that cancer death rates for people under 50 have dropped 44% from 1990 to 2023, driven by declines in breast cancer, leukemia, and especially lung cancer. However, colorectal cancer deaths in this age group have risen, making CRC the leading cancer killer under 50 by 2023. Experts cite possible factors like diet, obesity, and environmental exposures and stress the role of colonoscopy screening—ACS recommends starting regular screenings at age 45—in preventing deaths, though uptake in ages 45–49 remains a key target for reducing early-onset CRC.

via Yahoo|

#cancer-mortality #colonoscopies #colorectal-cancer

health4 months ago•3 min saved

U.S. Endorses At-Home HPV Testing to Improve Cervical Cancer Screening

Federal guidelines now allow women aged 30-65 at average risk to choose self-administered HPV tests every five years for cervical cancer screening, providing a more private and accessible option alongside traditional Pap smears, with the aim of increasing screening rates and early detection.

via NBC News|

#cervical-cancer #health #hpv-test

health11 months ago•3 min saved

Debate Over Prostate Cancer Testing Methods and Efficacy

The article discusses the pros and cons of PSA testing for prostate cancer, emphasizing that while it can produce false positives leading to unnecessary procedures, careful testing and risk assessment can help identify high-risk cases and save lives. The author supports PSA screening for men aged 50-70 and suggests that digital rectal exams add little value and often result in false positives, but individual discussions with doctors are important.

via OregonLive.com|

#dre #false-positives #health